EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between Sleep and Cardiovascular‐Kidney‐Metabolic Syndrome: Mediation Analysis of Inflammatory Biomarkers

Minjie Hu iD, Ying Xu iD, Jiao Ming iD, Xuelin Zhang iD, Xiaolu Bian iD, Xinrui Liang iD, Haiyan Wang iD, Longyi Zheng iD, Ying Zhang iD, Zhiyong Guo iD

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/9072641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 24.04.2026. Verfasst von Minjie Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, First Affiliated Hospital of Naval Medical University, Shanghai Changhai Hospital, Shanghai, China, chhospital.com.cn. Hauptthemen laut MEDLINE: Metabolic Syndrome, Inflammation, Biomarkers, Sleep. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Basic Medicine Project of Naval Medical University, Basic Medicine Research Program of the First Affiliated Hospital of Naval Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Sleep disturbances are linked to individual cardiometabolic diseases, but their association with the emerging cardiovascular‐kidney‐metabolic (CKM) syndrome, a constellation of interrelated conditions, remains less clear. To evaluate the association of sleep factors (sleep duration, diagnosed sleep disorder, self‐reported trouble sleeping) with the risk of CKM syndrome. Methods and Results We included 11,949 adults from the National Health and Nutrition Examination Survey (NHANES). A composite sleep score (0–3, from healthy to poor) was derived from sleep duration, diagnosed sleep disorder, and self‐reported trouble sleeping. CKM syndrome was defined and staged (Stage 0–4) based on the coexistence and severity of cardiometabolic and kidney diseases. Systemic inflammation was assessed using the systemic immune‐inflammation index (SII) and systemic inflammation response index (SIRI). A poor sleep pattern was significantly associated with higher odds of CKM syndrome (fully adjusted odds ratio [OR] = 1.64, 95% confidence interval (CI): 1.37–1.95) and with more advanced CKM stages in an ordinal model, indicating a dose–response relationship. In exploratory mediation analysis, SII and SIRI appeared to partially mediate the association between self‐reported trouble sleeping and CKM syndrome in initial models. However, this mediating effect was substantially attenuated and became nonsignificant for SII after comprehensive adjustment for adiposity (body mass index (BMI) and waist circumference) and lifestyle factors. Conclusions Poor sleep patterns are robustly associated with an increased risk and severity of CKM syndrome. While systemic inflammation was correlated with both sleep disturbances and CKM, its role as an independent mediator was largely explained by shared variance with obesity and metabolic factors. These findings underscore sleep health as a potential target for multimodal risk reduction within the CKM framework, though causality needs confirmation in longitudinal studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeInflammationBiomarkersSleepCardiovascular DiseasesHumansFemaleMaleMiddle AgedAdultSleep DurationNutrition SurveysSleep Wake DisordersMediation AnalysisRisk Factors

Stichwörter der Autor:innen

cardiovascular-kidney-metabolic syndromesleep patternsystemic immune inflammation indexsystemic immune response index

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Nephrology, First Affiliated Hospital of Naval Medical University, Shanghai Changhai Hospital, Shanghai, China, chhospital.com.cn.
  • Department of Nephrology, Huadong Hospital Affiliated to Fudan University, Shanghai, China, fudan.edu.cn.
  • Department of Endocrinology, First Affiliated Hospital of Naval Medical University, Shanghai Changhai Hospital, Shanghai, China, chhospital.com.cn.
  • Department of Clinical Pharmacy, General Hospital of Central Theater Command, Wuhan City, Hubei Province, China.

ORCID-Profile: Minjie Hu, Ying Xu, Jiao Ming, Xuelin Zhang, Xiaolu Bian, Xinrui Liang, Haiyan Wang, Longyi Zheng, Ying Zhang, Zhiyong Guo

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • Basic Medicine Project of Naval Medical University
  • Basic Medicine Research Program of the First Affiliated Hospital of Naval Medical University
  • Naval Medical University Nurse Funding
  • Scientific research project of Shanghai Nursing Association

Zitieren

APA

Hu, M., Xu, Y., Ming, J., Zhang, X., Bian, X., Liang, X., Wang, H., Zheng, L., Zhang, Y., & Guo, Z. (2026). Association Between Sleep and Cardiovascular‐Kidney‐Metabolic Syndrome: Mediation Analysis of Inflammatory Biomarkers. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/9072641

Vancouver

Hu M, Xu Y, Ming J, Zhang X, Bian X, Liang X, et al. Association Between Sleep and Cardiovascular‐Kidney‐Metabolic Syndrome: Mediation Analysis of Inflammatory Biomarkers. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/9072641

BibTeX
@article{Hu2026,
  author = {Hu, Minjie and Xu, Ying and Ming, Jiao and Zhang, Xuelin and Bian, Xiaolu and Liang, Xinrui and Wang, Haiyan and Zheng, Longyi and Zhang, Ying and Guo, Zhiyong},
  title = {Association Between Sleep and Cardiovascular‐Kidney‐Metabolic Syndrome: Mediation Analysis of Inflammatory Biomarkers},
  journal = {Mediators of Inflammation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/mi/9072641}
}
Kostenlos starten →